<DOC>
	<DOCNO>NCT00636844</DOCNO>
	<brief_summary>To identify patient risk heart damage receive chemotherapy ( adriamycin ) .</brief_summary>
	<brief_title>Detection Chemotherapy Induced Cardiotoxicity</brief_title>
	<detailed_description>To identify patient risk development heart damage receive chemotherapy obtain genetic profile show : elevation troponin , leave ventricular systolic diastolic dysfunction , pro-oxidant stress marker .</detailed_description>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>undergo anthracycline and/or trastuzumab therapy first time abnormal ventricular ejection fraction past history , active cardiac disease include : MI , CHF , angina , arrhythmia require medication , valvular disease , uncontrolled systemic hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>chemotherapy , cardiotoxicity</keyword>
</DOC>